Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
These names are displaying both technical and quantitative deterioration.
Learn to sell without regret and you will be a better trader.
I think that it's pretty telling that Amazon is up and United Parcel and FedEx are down.
Aflac is a dividend aristocrat that offers a safe yield and strong total returns.